GE HealthCare Technologies Inc. $GEHC Shares Bought by State of Wyoming

State of Wyoming grew its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 173.1% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 13,530 shares of the company’s stock after acquiring an additional 8,575 shares during the period. State of Wyoming’s holdings in GE HealthCare Technologies were worth $1,016,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of GEHC. Dodge & Cox boosted its stake in shares of GE HealthCare Technologies by 42.1% in the 2nd quarter. Dodge & Cox now owns 23,567,950 shares of the company’s stock valued at $1,745,678,000 after buying an additional 6,982,441 shares during the period. Norges Bank purchased a new stake in shares of GE HealthCare Technologies in the 2nd quarter valued at approximately $468,120,000. Holocene Advisors LP raised its holdings in shares of GE HealthCare Technologies by 178.5% in the 2nd quarter. Holocene Advisors LP now owns 4,027,352 shares of the company’s stock valued at $298,306,000 after purchasing an additional 2,581,522 shares in the last quarter. Menora Mivtachim Holdings LTD. purchased a new stake in shares of GE HealthCare Technologies during the 2nd quarter worth $80,755,000. Finally, Balyasny Asset Management L.P. acquired a new position in shares of GE HealthCare Technologies during the second quarter worth $58,388,000. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of analysts have weighed in on GEHC shares. Morgan Stanley raised their price target on GE HealthCare Technologies from $74.00 to $80.00 and gave the company an “equal weight” rating in a research note on Thursday, October 30th. Weiss Ratings reiterated a “hold (c+)” rating on shares of GE HealthCare Technologies in a report on Monday, December 29th. Bank of America boosted their target price on GE HealthCare Technologies from $82.00 to $92.00 and gave the stock a “neutral” rating in a research note on Monday, January 5th. Jefferies Financial Group upped their price target on GE HealthCare Technologies from $95.00 to $105.00 and gave the company a “buy” rating in a report on Thursday, December 11th. Finally, Barclays initiated coverage on shares of GE HealthCare Technologies in a report on Monday, October 13th. They set an “equal weight” rating and a $86.00 price objective on the stock. Seven research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, GE HealthCare Technologies has a consensus rating of “Hold” and a consensus target price of $90.33.

GE HealthCare Technologies Stock Up 0.2%

GEHC stock opened at $78.97 on Monday. The company has a market cap of $35.97 billion, a price-to-earnings ratio of 16.32, a price-to-earnings-growth ratio of 2.38 and a beta of 1.09. The company has a fifty day moving average price of $82.63 and a 200 day moving average price of $77.38. The company has a debt-to-equity ratio of 0.83, a current ratio of 1.18 and a quick ratio of 0.95. GE HealthCare Technologies Inc. has a 12 month low of $57.65 and a 12 month high of $94.80.

GE HealthCare Technologies Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Friday, January 9th will be given a $0.035 dividend. This represents a $0.14 annualized dividend and a yield of 0.2%. The ex-dividend date is Friday, January 9th. GE HealthCare Technologies’s payout ratio is 2.89%.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.